Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Tofacitinib is effective and safe for treating severe alopecia areata.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib helped a woman regrow hair with no major side effects.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.